Freedom Capital upgraded Intuitive Surgical (ISRG) to Buy from Hold with a price target of $610, up from $560. The firm believes the rollout of the da Vinci 5 will support Intuitive’s system sales and procedure volumes in 2026. It cites higher revenue expectations for 2026 and 2027 for the upgrade.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical says Da Vinci 5 cleared for cardiac procedures
- Intuitive Surgical price target raised to $712 from $686 at Barclays
- Intuitive Surgical Earnings Call: Growth Surges, Margins Pinched
- Intuitive Surgical’s JURA Feasibility Study: Early Imaging Data With Long-Term Upside for Investors
- Intuitive says over 20M patients operated on with use of da Vinci systems